Gareth J. Morgan, MD, PhD, and Faith E. Davies, MD, both leading experts in hematology, are joining the Center for Blood Cancers at NYU Langone’s Perlmutter Cancer Center to lead its Multiple Myeloma Program.
As director of the new center’s multiple myeloma research, Dr. Morgan is focusing on developing new targeted treatments for high-risk variants of myeloma.
Dr. Davies, director of the Clinical Myeloma Program, brings her extensive leadership skills to the center and will direct a new inpatient facility in Kimmel Pavilion.
“We are extremely excited that Drs. Morgan and Davies have joined our new Center for Blood Cancers,” says Benjamin G. Neel, MD, PhD, director of Perlmutter Cancer Center. “They each have long, internationally recognized histories of leadership in myeloma research and clinical care. As a National Cancer Institute–designated Comprehensive Cancer Center, we are proud to be on the cutting edge of bringing new, improved treatments to patients with myeloma and other blood cancers.”